Drug Trial Radar · NCT05712421
A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism
Last checked: Nov 20, 2026Latest source record: Feb 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
303
Actual
Start
Feb 28, 2023
Primary completion
May 5, 2025
Study completion Sep 18, 2025
Sponsor
- Lead sponsor
- Neuvosyn Laboratories, LLCIndustry
- Sponsor type
- Industry
- First posted
- Feb 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The North Star study is a multi-center, Phase 2, double-blind, randomized, parallel group clinical study to evaluate the safe and effective dose conversion from Levothyroxine to North Star therapy.
Conditions
- Hypothyroidism
Interventions
North StarDrug
North Star
LevothyroxineDrug
Levothyroxine
Primary outcomes
What the sponsor says the trial is designed to measure.
- The ratio of the LT4 dose (mcg/day) at screening to North Star (mg/day) at the end of the treatment period required to achieve and maintain serum thyroid-stimulating hormone (TSH) levels within the normal reference range.Time frame: Week 30
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
Neuvosyn Investigational Site
Birmingham, Alabama
Neuvosyn Investigational Site
Canoga Park, California
Neuvosyn Investigational Site
Greenbrae, California
Neuvosyn Investigational Site
Toluca Lake, California
Neuvosyn Investigational Site
Farmington, Connecticut
Neuvosyn Investigational Site
Boca Raton, Florida
Neuvosyn Investigational Site
Miami, Florida
Neuvosyn Investigational Site
Miami, Florida
Neuvosyn Investigational Site
Miami, Florida
Neuvosyn Investigational Site
Miami, Florida
Neuvosyn Investigational Site
Miami, Florida
Neuvosyn Investigational Site
Sunrise, Florida
Neuvosyn Investigational Site
Acworth, Georgia
Neuvosyn Investigational Site
Atlanta, Georgia
Neuvosyn Investigational Site
Columbus, Georgia
Neuvosyn Investigational Site
Sugar Hill, Georgia
Neuvosyn Investigational Site
Saginaw, Michigan
Neuvosyn Investigational Site
Gladstone, Missouri
Neuvosyn Investigational Site
Williamsville, New York
Neuvosyn Investigational Site
Denver, North Carolina
Neuvosyn Investigational Site
Winston-Salem, North Carolina
Neuvosyn Investigational Site
Beavercreek, Ohio
Neuvosyn Investigational Site
Columbus, Ohio
Neuvosyn Investigational Site
Georgetown, Texas
Neuvosyn Investigational Site
Houston, Texas
Neuvosyn Investigational Site
Katy, Texas
Neuvosyn Investigational Site
Katy, Texas
Neuvosyn Investigational Site
Lewisville, Texas
Neuvosyn Investigational Site
Paris, Texas
Neuvosyn Investigational Site
Pearland, Texas
Neuvosyn Investigational Site
Stafford, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.